A large clinical trial suggests that a daily multivitamin may influence the pace at which the body ages. Researchers led by Mass General Brigham report that older adults who took a daily multivitamin ...

Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows.

Initial treatments are underway in randomized study of Acorn’s personalized autologous injectable for improving facial ...

Severe acute pancreatitis is frequently complicated by hospital-acquired infections that worsen outcomes and prolong intensive care stays. New evidence suggests that modulating the microbiome may ...

Psychedelic therapy is a promising approach for tackling tobacco addiction, early results of a pilot clinical trial show in which psilocybin outperformed nicotine patches in helping smokers quit.

The median fraction of the gland reaching ablative temperatures on intra-procedural MRI thermometry was 78% (IQR 71-85), with 68% of cases comprising whole gland ablation and 32% sub-total ablation: ...

Low dose alnodesertib plus gemcitabine met the primary endpoint of progression-free survival (PFS) versus gemcitabine alone ...

Sivelestat significantly reduced the incidence of postoperative ARDS, lowered 90-day mortality, and suppressed inflammatory biomarkers linked to lung injury.

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer Patients age 20 years and ...

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study This randomized, parallel-group, phase II study ...